Role of Second-Trimester Genetic Sonography After Down Syndrome Screening

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Obstetrics and Gynecology

• Publication date

  2009-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/AOG.0b013e3181c15064PMID 19935018PMCID PMC4824304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AIUM Practice Guideline for the Performance of Obstetric Ultrasound Examinations

  2013cited by this paper
• AIUM Practice Guideline for the Performance of Obstetric Ultrasound Examinations

  2010cited by this paper
• Prenasal thickness in trisomy‐21 fetuses at 16–24 weeks of gestation

  2008cited by this paper
• Contingent screening for Down syndrome—results from the FaSTER trial

  2008cited by this paper
• Expected performance of second trimester maternal serum testing followed by a ‘genetic sonogram’ in screening of fetal Down syndrome

  2008cited by this paper
• Correlation between nuchal translucency and nuchal skin‐fold measurements in Down syndrome and unaffected fetuses

  2008cited by this paper
• Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of Down syndrome

  2007cited by this paper
• Births: final data for 2005.

  2007cited by this paper
• Genetic sonography after first‐trimester Down syndrome screening

  2007cited by this paper
• Ultrasound Findings After Screening for Down Syndrome Using the Integrated Test

  2007cited by this paper
• Frontomaxillary facial angles in screening for trisomy 21 at 14-23 weeks' gestation.

  2007cited by this paper
• Combining fetal nuchal fold thickness with second‐trimester biochemistry to screen for trisomy 21

  2006cited by this paper
• The impact of gestational age on the sonographic detection of aneuploidy.

  2005cited by this paper
• First-trimester or second-trimester screening, or both, for Down's syndrome.

  2005cited by this paper
• Second trimester ultrasound prenasal thickness combined with nasal bone length: a new method of Down syndrome screening

  2005cited by this paper
• Screening for chromosomal defects

  2003cited by this paper
• Combined Second‐Trimester Biochemical and Ultrasound Screening for Down Syndrome

  2002cited by this paper
• The Genetic Sonogram

  2002cited by this paper
• Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy.

  2001cited by this paper
• Relationship between nuchal translucency at 11–14 weeks and nuchal fold at 20–24 weeks of gestation

  2001cited by this paper
• Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis.

  2001cited by this paper
• Age‐adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases

  1998cited by this paper
• Natural history of trisomy 21 fetuses with increased nuchal translucency thickness

  1995cited by this paper
• Sonographic Scoring Index for Prenatal Detection of Chromosomal Abnormalities

  1992cited by this paper
• Model-based screening by risk with application to Down's syndrome.

  1992cited by this paper

• Use of Prenasal Thickness, Nasal Bone Length and Their Ratio in Diagnosing Down Syndrome at 16‐25 weeks' of gestation in India: A Retrospective, Observational, Case Control Study

  2025cites this paper
• Prenatal Screening for Chromosomal Defects

  2025cites this paper
• Clinical and economic impact of genome-wide non-invasive prenatal testing (NIPT) as a first-tier screening method compared to targeted NIPT and first-trimester combined testing: A modeling study

  2025cites this paper
• Recurrent Pregnancy Loss

  2025cites this paper
• The likelihood of detecting abnormal karyotypes in fetuses with a single major anomaly or “soft” marker on ultrasonographic scanning

  2024cites this paper
• Comparison of the ratio of second trimester fetal biometric measurements to fetal nasal bone length in fetuses with normal karyotype and trisomy 21

  2024cites this paper
• Directive clinique N° 456 : Dépistage prénatal des anomalies chromosomiques fœtales.

  2024cites this paper
• Guideline No. 456: Prenatal Screening for Fetal Chromosomal Anomalies.

  2024cites this paper
• Superior mesenteric artery Doppler parameters in the evaluation of fetal hyperechogenic bowel

  2023cites this paper
• Nasal bone in fetal aneuploidy risk assessment: are they independent markers in the first and second trimesters?

  2022cites this paper
• Ethnic-specific reference range affects the efficacy of quadruple test as a universal screening for Down syndrome in a developing country

  2021cites this paper
• Novel method for trisomy 21 screening in the first trimester of pregnancy: fetal brain angle

  2021cites this paper
• Society for Maternal-Fetal Medicine (SMFM) Consult Series #57: Evaluation and Management of Isolated Soft Ultrasound Markers for Aneuploidy in the Second Trimester.

  2021cites this paper
• Missed Down Syndrome Cases after First Trimester False-Negative Screening—Lessons to be Learned

  2020cites this paper
• Isolated echogenic intracardiac foci and the role of cell‐free fetal DNA: A cost‐effectiveness analysis

  2020influential citation
• The current state of prenatal detection of genetic conditions in congenital heart defects

  2020cites this paper
• Prenatal genetic considerations in congenital ventriculomegaly and hydrocephalus

  2020cites this paper
• Outcome of fetal echogenic bowel: A systematic review and meta‐analysis

  2020cites this paper
• Prenatal chromosomal microarray analysis in 2466 fetuses with ultrasonographic soft markers: a prospective cohort study.

  2020cites this paper
• Ultrasound and Biochemical Screening for Fetal Aneuploidy

  2020cites this paper
• Femur length parameters in fetuses with Down syndrome†

  2020cites this paper
• Role of Second-Trimester Soft Markers for Screening of Down Syndrome

  2020cites this paper
• Ultrasound Markers for Aneuploidy in the Second Trimester

  2019cites this paper
• A Bayesian risk analysis for Trisomy 21 in isolated choroid plexus cyst: combining a prenatal database with a meta-analysis

  2019cites this paper
• Fetal cardiac examination can affect patients’ preference on invasive tests

  2019cites this paper
• Rethinking second‐trimester Down‐syndrome screening in the cell‐free DNA era

  2019cites this paper
• Genetic Evaluation of Fetal Sonographic Abnormalities

  2019cites this paper
• Isolated Echogenic Cardiac Focus: Assessing Association with Trisomy 21 by Combining Results from a Prenatal Center with a Bayesian Meta-Analysis

  2019cites this paper
• Gendiagnostik in der Geburtshilfe – klares Konzept, verständliche ärztliche Beratung

  2018cites this paper
• Number of Risk Factors in Down Syndrome Pregnancies

  2018cites this paper
• Prenatal diagnosis

  2018cites this paper
• Introduction to Aneuploidy

  2018cites this paper
• Prenatal screening of aneuploidies and adverse pregnancy outcome : The significance of second trimester soft markers and low first trimester PAPP-A

  2017cites this paper
• Prenatal Diagnosis of the Human Embryo and Fetus

  2017cites this paper
• Screening for Fetal Aneuploidy

  2017cites this paper
• No. 261-Prenatal Screening for Fetal Aneuploidy in Singleton Pregnancies.

  2017cites this paper
• 1090 Obstetric and Fetal Sonography PART IV

  2017cites this paper
• First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

  2017cites this paper
• Congenital Anomalies in Human Embryos

  2017cites this paper
• QUAD versus cfDNA in an urban population in the second trimester for detection of trisomy 21: a cost sensitivity analysis

  2017cites this paper
• Meta-analysis of validity of echogenic intracardiac foci for calculating the risk of Down syndrome in the second trimester of pregnancy.

  2017cites this paper
• Is an isolated ventricular septal defect detected before 24 weeks on ultrasound associated with fetal aneuploidy?*

  2016cites this paper
• Screening for fetal aneuploidy.

  2016cites this paper
• Development of prenatal screening--A historical overview.

  2016cites this paper
• Practice Bulletin No. 163: Screening for Fetal Aneuploidy

  2016cites this paper
• Evaluation of the adequacy of reference charts for the accurate identification of fetuses with bone length below the 5th percentile

  2016cites this paper
• Maternal Serum Screening for Chromosomal Abnormalities and Neural Tube Defects

  2015cites this paper
• Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis

  2015cites this paper
• Soft markers for aneuploidy following reassuring first trimester screening: what should be done?

  2015cites this paper
• Suspicious Prenasal Skin Thickness-to-Nasal Bone Length Ratio: Prevalence and Correlation with Other Markers in Second and Third Trimester Fetuses with Down Syndrome

  2015cites this paper
• Isolated intracardiac echogenic focus on routine ultrasound: implications for practice.

  2015cites this paper
• Prenatal Diagnosis of Chromosomal Abnormalities through Chorionic Villus Sampling and Amniocentesis

  2015cites this paper
• Relationship between mid‐trimester ultrasound fetal liver length measurements and gestational diabetes mellitus 妊娠中期三个月超声测量的胎儿肝脏长度与妊娠期糖尿病之间的关系

  2015cites this paper
• Impact of Gestational Age on Nuchal Fold Thickness in the Second Trimester

  2014cites this paper
• The role of ultrasound in the diagnosis of fetal genetic syndromes.

  2014cites this paper
• Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society

  2014cites this paper
• Fetal Imaging

  2014cites this paper
• Prenatal Screening Using Maternal Markers

  2014cites this paper
• Second trimester genetic ultrasound for Down syndrome screening at Srinagarind Hospital.

  2014cites this paper
• Role of the second‐trimester ‘genetic sonogram’ for Down syndrome screen in the era of first‐trimester screening and noninvasive prenatal testing

  2014cites this paper
• Fetal imaging: Executive summary of a Joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society

  2014cites this paper
• Nasal bone length: prenasal thickness ratio: a strong 2D ultrasound marker for Down syndrome

  2014cites this paper
• The Role of Fetal Echocardiography in the Assessment of Fetal Aneuploidy

  2014cites this paper
• Analysis of Second Trimester Maternal Quadruple Screening Test for Trisomy 21 and Trisomy 18

  2014cites this paper
• What Is the Importance of Second‐Trimester “Soft Markers” for Trisomy 21 After an 11‐ to 14‐Week Aneuploidy Screening Scan?

  2014cites this paper
• Prenatal screening strategies, long-term outcome of children with marked changes in maternal screening tests and the most common syndromic heart anomalies in Estonia

  2014cites this paper
• Limitations of Aneuploidy and Anomaly Detection in the Obese Patient

  2014cites this paper
• THE GENETIC SONOGRAM

  2014cites this paper
• A New Model for Providing Cell-Free DNA and Risk Assessment for Chromosome Abnormalities in a Public Hospital Setting

  2014cites this paper
• Influence of Second-Trimester Ultrasound Markers for Down Syndrome in Pregnant Women of Advanced Maternal Age

  2014cites this paper
• GENETIC SONOGRAM: COMPONENTS AND ROLE IN THE ERA OF PRENATAL SCREENING

  2014cites this paper
• Second Trimester Ultrasound Markers of Fetal Aneuploidy

  2014cites this paper
• Maternal obesity and Down syndrome in the offspring: is there a link?

  2014cites this paper
• Follow-up of sonographically detected soft markers for fetal aneuploidy.

  2013cites this paper
• Meta‐analysis of second‐trimester markers for trisomy 21

  2013cites this paper
• Role of second‐trimester ultrasound in screening for Down syndrome

  2013cites this paper
• THE MATERNAL-FETAL MEDICINE: AN UPDATE

  2013cites this paper
• Echogenic intracardiac foci: disclosure and the rate of amniocentesis in low-risk patients.

  2013cites this paper
• Isolated fetal pyelectasis and the risk of Down syndrome: a meta‐analysis

  2013cites this paper
• Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis

  2013cites this paper
• Efficacy of the Genetic Sonogram in a Stepwise Sequential Protocol for Down Syndrome Screening

  2013cites this paper
• New contingent sequential screening model for Down syndrome based on the combined test associated with modified genetic sonography

  2013cites this paper
• Pränataldiagnostik Erweiterung durch genetische Erkenntnisse

  2012cites this paper
• Obesity and the risk and detection of fetal malformations.

  2012cites this paper
• Contribution of “modified genetic sonography” to the combined test as a screening method for chromosomal abnormalities

  2012cites this paper
• Second‐trimester soft markers: relation to first‐trimester nuchal translucency in unaffected pregnancies

  2012cites this paper
• Survey of prenatal counselling practices regarding aneuploidy risk modification, invasive diagnostic procedure risks, and procedure eligibility criteria in Canadian centres.

  2012cites this paper
• Role of fetal echocardiography in stepwise sequential screening for chromosomal disorders (combined test associated with modified genetic sonography)

  2012influential citation
• Stepwise sequential screening for Down’s syndrome (combined test associated with modified genetic sonography) in pregnant women with low risk for chromosomal disorders

  2012cites this paper
• Prenatal Ultrasound to Detect Fetal Anomalies

  2012cites this paper
• First‐ and Second‐Trimester Screening for Fetal Aneuploidy and Neural Tube Defects

  2012cites this paper
• Ultrasonographic soft markers of aneuploidy in second trimester fetuses

  2012cites this paper
• Impact of prenatal screening on future resource utilization in pregnancy

  2012cites this paper
• Prenatal screening for fetal aneuploidy.

  2011cites this paper
• Pränataldiagnostik

  2011cites this paper
• Efectividad del doble test bioquímico como prueba de cribado de síndrome de Down en el segundo trimestre

  2011cites this paper
• Dépistage prénatal de l’aneuploïdie fœtale en ce qui concerne les grossesses monofœtales

  2011cites this paper
• First and second trimester sonographic screening for fetal Down syndrome

  2011cites this paper
• Relação entre a medida da translucência nucal no primeiro trimestre e a presença de marcadores ultrassonográficos para a Síndrome de Down no segundo trimestre da gestação

  2011cites this paper
• Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011

  2011cites this paper